BioScience Health Innovations, Inc.
BHIC
$1.00
-$8.01-88.90%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 357.44% | 342.04% | 100.99% | 198.13% | 452.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 357.44% | 342.04% | 100.99% | 198.13% | 452.81% |
| Cost of Revenue | 825.47% | 673.13% | 304.17% | 366.04% | 676.84% |
| Gross Profit | 246.17% | 281.64% | 43.34% | 164.94% | 417.33% |
| SG&A Expenses | 161.13% | 62.89% | 19.72% | 69.43% | 62.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 319.43% | 141.78% | 75.53% | 107.30% | 100.32% |
| Operating Income | 516.85% | 899.25% | 126.04% | 198.42% | 186.99% |
| Income Before Tax | 516.85% | 899.25% | 126.04% | 198.42% | 186.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 516.85% | 899.25% | 126.04% | 198.42% | 186.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 516.85% | 899.25% | 126.04% | 198.42% | 186.99% |
| EBIT | 516.85% | 899.25% | 126.04% | 198.42% | 186.99% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 477.78% | 846.15% | 122.22% | 192.86% | 185.71% |
| Normalized Basic EPS | 490.91% | 862.50% | 116.67% | 188.89% | 184.62% |
| EPS Diluted | 455.56% | 846.15% | 106.45% | 192.86% | 185.71% |
| Normalized Diluted EPS | 490.91% | 850.00% | 116.67% | 188.89% | 184.62% |
| Average Basic Shares Outstanding | 5.58% | 6.10% | 4.58% | 4.28% | 4.40% |
| Average Diluted Shares Outstanding | 5.52% | 7.11% | 8.70% | 4.28% | 5.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |